If your doctor has recommended a bisphosphonate, you've probably gone home and started reading about it. Some of what you found was reassuring. Some of it was scary. I understand the uncertainty. As a physician and an osteoporosis patient myself, I want to walk you through what I think every patient should understand about these medications.
What They Are and How They Work
Bisphosphonates are the most commonly prescribed medications for osteoporosis. They've been in use since the 1990s, which means we have decades of data on how they perform. The American College of Physicians updated their guidelines to make bisphosphonates the clear first-line treatment for osteoporosis, based on their proven track record of fracture protection, strong safety profile, and broad availability as generics.
The way they work is straightforward. Your bones are constantly remodeling themselves. Specialized cells called osteoclasts break down old bone, and other cells called osteoblasts build new bone in its place. In osteoporosis, the breakdown outpaces the rebuilding. Bisphosphonates slow down the osteoclasts. They literally bind to bone tissue and reduce the rate at which bone is removed. This allows the bone-building cells to catch up, and over time, your bone density stabilizes or improves.
The most commonly prescribed bisphosphonates include alendronate (Fosamax), risedronate (Actonel), and ibandronate (Boniva), taken as pills weekly or monthly. There's also zoledronic acid (Reclast), given as an IV infusion once a year. Your doctor will recommend one based on your fracture history, your other medications, and your lifestyle.
The Fears People Have
Almost everyone I talk to about bisphosphonates brings up two concerns: jaw problems and unusual fractures. These fears are real, but the actual risk numbers tell a more complete story.
Osteonecrosis of the jaw (ONJ) is a condition where a portion of the jawbone fails to heal properly, usually after a dental procedure. It sounds frightening. But in patients taking oral bisphosphonates for osteoporosis, a study published in the Journal of Oral and Maxillofacial Surgery found the prevalence was approximately 1 in 952 patients. That's roughly 0.1%. The much higher rates you may have seen reported are from cancer patients receiving intravenous bisphosphonates at far higher doses and frequencies than those used for osteoporosis.
Atypical femur fractures are stress fractures of the thigh bone that can occur with very long-term bisphosphonate use. They are also very rare, and the risk increases primarily after 5 or more years of continuous treatment. This is one of the reasons for "drug holidays," which I'll explain in a moment.
Compare those small risks to this: without treatment, an estimated one in two women over 50 will experience an osteoporotic fracture. Hip fractures carry a 20% mortality rate within the first year. The math strongly favors treatment.
Taking Them Correctly Matters
Oral bisphosphonates can irritate the esophagus, which is why the instructions sound so specific. Take the pill first thing in the morning on an empty stomach with a full glass of plain water (not coffee, not juice, not sparkling water). Stay upright for at least 30 minutes afterward and don't eat or drink anything else during that time.
It requires a small restructuring of your morning routine. But the reason for these rules is practical: food and other beverages dramatically reduce absorption, and lying down can cause the pill to sit in your esophagus and irritate the tissue. Follow the instructions, and side effects are far less likely.
If the weekly or monthly pill routine doesn't work for you, ask your doctor about the annual IV infusion option. Zoledronic acid is given once a year in a 15-minute infusion and eliminates the daily or weekly compliance issue entirely.
The Drug Holiday
One of the unique features of bisphosphonates is that they accumulate in your bone tissue and continue working even after you stop taking them. Because of this, doctors often recommend a "drug holiday" after a period of treatment: typically 3 to 5 years for patients at lower fracture risk, or up to 10 years for those at higher risk.
During the holiday, the bisphosphonate stored in your bones continues to provide some protection. Your doctor will monitor your bone density periodically and restart medication if your numbers begin to decline or if you have a new fracture. The Mayo Clinic notes that this phased approach helps reset bone dynamics while residual medication continues to provide ongoing protection.
An important caveat: drug holidays apply only to bisphosphonates. Other osteoporosis medications, like denosumab (Prolia), work differently and cannot simply be stopped. Discontinuing denosumab without starting another medication can lead to rapid bone loss and rebound fractures. This is a critical distinction worth discussing with your doctor.
Having the Conversation
If your doctor has recommended a bisphosphonate and you're hesitant, bring your questions rather than quietly declining the prescription. Too many patients leave the office with a prescription they never fill because they read something alarming online and didn't feel comfortable asking about it.
Some questions worth bringing to your next appointment:
- Which bisphosphonate do you recommend for me, and why?
- Would an alternative be to commit to bone-building exercise and nutrition and recheck my bone density after one year?
- Is there anything about my situation that might mean I should take one of the newer anabolic (bone-building) medications instead?
- How long do you anticipate I'll need to take it?
- What should I do before any dental procedures while on this medication?
- When will we reassess whether I still need it?
You and your doctor are on the same team. The goal is to reduce your fracture risk with the least side effects. Bisphosphonates have helped millions of people do exactly that. They're not perfect, and they're not the only option. But they are effective, well-studied, and for most patients, the benefit outweighs the risk.